Oxygenated Species of Cardiolipins as Biomarkers of Mitochondrial Dysfunction
Oxygenated Species of Cardiolipins as Biomarkers of Mitochondrial Dysfunction
批准号:
8334604
负责人:
Valerian E Kagan
金额:
$34.09万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-19 至 2016-06-30
关键词:
AffectAgeApoptosisApoptoticBiological MarkersBrainCardiolipinsCellsCessation of lifeCharacteristicsChromatographyCytosolDevelopmentDiagnosisDiseaseDopamineDoseExposure toFatty AcidsFingersGenesGoalsHeatingHumanImpairmentIn VitroIncidenceIndividualInfusion proceduresLinkLiquid ChromatographyMapsMidbrain structureMitochondriaModelingModificationMolecularMutateNatureNeuroblastomaNeurodegenerative DisordersNeuronsOutcomeOxidative StressParkinson DiseasePathway interactionsPatientsPatternPeripheral Blood LymphocytePesticidesPhospholipidsPolyunsaturated Fatty AcidsPopulationPrintingProtocols documentationRattusReactionReactive Oxygen SpeciesResolutionRoleRotenoneSmall Interfering RNASubstantia nigra structureSystemTechniquesTestingTimeUnited StatesWorkbasecardiolipin synthasecytochrome cin vivomitochondrial dysfunctionneuron apoptosisnoveloxidationperoxidation
中文摘要
本申请的目标是鉴定环境诱导的(鱼藤酮-)磷脂生物标志物。
诱导的)与帕金森病PD相关的线粒体功能障碍。我们证明,
线粒体特异性磷脂心磷脂(CL)在细胞色素c催化下发生选择性氧化
(cyt c)神经元凋亡早期。我们的中心假设是接触杀虫剂鱼藤酮,
导致CL的时间和剂量依赖性选择性氧化和其氧化的蓄积
与通过酶促细胞色素C催化的线粒体功能障碍相关的分子种类
在凋亡早期触发的反应。CL分子种类的独特概况代表了一种新的
鱼藤酮诱导的与PD相关的线粒体功能障碍的生物标志物类型。使用氧化
脂质组学方法,我们将首先确定大鼠中诱导的CL氧化分子种类的特定模式,
鱼藤酮对原代皮层和中脑神经元以及神经母细胞瘤SH-SY 5 Y的作用。此外,我们将
揭示了使用大鼠鱼藤酮在多巴胺能和皮质神经元中氧化CL物质的特异性特征,
PD输注模型。最后,我们将建立鱼藤酮特异性CL氧化模式的存在,
人外周血淋巴细胞暴露于鱼藤酮,并与
鱼藤酮灌注大鼠模型。为了检验假设,制定了以下具体目标:
1将利用氧化脂质组学来鉴定和表征CL的分子种类,
CL在原代大鼠皮层神经元和中脑中的独特立体特异性氧合产物
神经元以及SH-SY 5 Y细胞暴露于鱼藤酮。具体目标2将建立
细胞色素c与CL相互作用参与CL氧化的机制和途径,
原代大鼠皮质和中脑神经元以及暴露于鱼藤酮的SH-SY 5 Y细胞。具体
目的3将确定鱼藤酮诱导的过氧化CL的分子种类
在体外神经元中检测和鉴定,在皮质和中脑的线粒体中积累
鱼藤酮灌注大鼠后,体内神经元。Specific Aim 4将揭示鱼藤酮特异性CL
人外周血淋巴细胞线粒体过氧化模式
与PD相关的功能障碍。
英文摘要
The goal of this application is to identify phospholipid biomarkers of environmentally-induced (rotenone-
induced) mitochondrial dysfunction associated with Parkinson's disease PD. We demonstrated that a
mitochondria specific phospholipid, cardiolipin (CL), undergoes selective oxidation catalyzed by cytochrome c
(cyt c) early during neuronal apoptosis. Our central hypothesis is that exposure to a pesticide, rotenone,
causes time- and dose-dependent selective oxidation of CL and accumulation of its oxidized
molecular species associated with mitochondrial dysfunction through enzymatic cyt c catalyzed
reactions triggered early in apoptosis. The unique profile of CL molecular species represents a new
type of biomarkers of rotenone-induced mitochondrial dysfunction associated with PD. Using oxidative
lipidomics approach we will first identify specific patterns of CL oxidized molecular species induced in rat
primary cortical and midbrain neurons as well as neuroblastoma SH-SY5Y by rotenone. Further, we will
reveal the specific profiles of oxidized CL species in dopaminergic and cortical neurons using rat rotenone-
infusion model of PD. Finally we will establish the presence of the rotenone-specific CL oxidation patterns in
human peripheral blood lymphocytes exposed to rotenone and compare them with those detected in
rotenone-infusion rat model. The following Specific Aims were developed to test the hypothesis: Specific Aim
1 will utilize oxidative lipidomics to identify and characterize molecular species of CL as well as
unique stereo-specific oxygenated products of CL in primary rat cortical neurons and midbrain
neurons as well as in SH-SY5Y cells upon exposure to rotenone. Specific Aim 2 will establish the
mechanisms and pathways through which interactions of cyt c with CL are involved in CL oxidation in
primary rat cortical and midbrain neurons as well as SH-SY5Y cells exposed to rotenone. Specific
Aim 3 will determine the extent to which molecular species of rotenone-induced peroxidized CL
detected and identified in neurons in vitro accumulate in mitochondria of cortical and midbrain
neurons in vivo after infusion of rotenone to rats. Specific Aim 4 will reveal rotenone-specific CL
peroxidation patterns in human peripheral blood lymphocytes as biomarkers of mitochondrial
dysfunction associated with PD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic targeting MDSC-mediated immune suppression in cancer
-
批准号:10340589
-
项目类别:
-
资助金额:$71.44万
-
财政年份:2021
-
负责人:Valerian E Kagan
-
依托单位:
Therapeutic targeting MDSC-mediated immune suppression in cancer
-
批准号:10540357
-
项目类别:
-
资助金额:$68.26万
-
财政年份:2021
-
负责人:Valerian E Kagan
-
依托单位:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
-
批准号:10593942
-
项目类别:
-
资助金额:$53.51万
-
财政年份:2020
-
负责人:Valerian E Kagan
-
依托单位:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
-
批准号:10176413
-
项目类别:
-
资助金额:$53.45万
-
财政年份:2020
-
负责人:Valerian E Kagan
-
依托单位:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
-
批准号:10408142
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2020
-
负责人:Valerian E Kagan
-
依托单位:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
-
批准号:10375454
-
项目类别:
-
资助金额:$54.0万
-
财政年份:2020
-
负责人:Valerian E Kagan
-
依托单位:
The molecular basis of cardiolipin-protein interactions implicated in intrinsic apoptosis
-
批准号:9342976
-
项目类别:
-
资助金额:$36.58万
-
财政年份:2016
-
负责人:Valerian E Kagan
-
依托单位:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
-
批准号:10399560
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
NANOTOX 2014, 7th International Nanotoxicology Congress
-
批准号:8718354
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Intra- and extra-cellular signaling by Cardiolipin in Lung injury
-
批准号:8643330
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Oxidative Lipidomics Core
-
批准号:8643333
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
-
批准号:10631057
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
-
批准号:10204081
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2014
-
负责人:Valerian E Kagan
-
依托单位:
Lipids and Myeloid Cell Function in Cancer
-
批准号:10435498
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Lipids and Myeloid Cell Function in Cancer
-
批准号:10021537
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Imaging Mass Spectrometry for Oxidized Lipidomics in Acute Lung Injury
-
批准号:8234264
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Imaging Mass Spectrometry for Oxidized Lipidomics in Acute Lung Injury
-
批准号:8423711
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Lipids and Myeloid Cell Function in Cancer
-
批准号:10202494
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2012
-
负责人:Valerian E Kagan
-
依托单位:
Oxygenated Species of Cardiolipins as Biomarkers of Mitochondrial Dysfunction
-
批准号:8691815
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2011
-
负责人:Valerian E Kagan
-
依托单位:
Oxygenated Species of Cardiolipins as Biomarkers of Mitochondrial Dysfunction
-
批准号:8485605
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2011
-
负责人:Valerian E Kagan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: